Helicobacter pylori Antibiotic Resistance: What is the Future of Treatment?

authors:

avatar Mohammad Zamani ORCID 1 , * , avatar Vahid Zamani 2 , avatar Javad Shokri-Shirvani 3

Student Research Committee, Babol University of Medical Sciences, Babol, IR Iran
Vice-Chancellery for Health, Babol University of Medical Sciences, Babol, IR Iran
Department of Internal Medicine, Rohani Hospital, Babol University of Medical Sciences, Babol, IR Iran

how to cite: Zamani M, Zamani V, Shokri-Shirvani J. Helicobacter pylori Antibiotic Resistance: What is the Future of Treatment?. Iran J Pediatr. 2016;26(4):e5333. https://doi.org/10.5812/ijp.5333.

References

  • 1.

    Maleknejad S, Mojtahedi A, Safaei-Asl A, Taghavi Z, Kazemnejad E. Primary Antibiotic Resistance to Helicobacter pylori Strains Isolated From Children in Northern Iran: A Single Center Study. Iran J Pediatr. 2015;25(6):2661. [PubMed ID: 26635938]. https://doi.org/10.5812/ijp.2661.

  • 2.

    Horvath A, Dziechciarz P, Szajewska H. Meta-analysis: sequential therapy for Helicobacter pylori eradication in children. Aliment Pharmacol Ther. 2012;36(6):534-41. [PubMed ID: 22827718]. https://doi.org/10.1111/j.1365-2036.2012.05229.x.

  • 3.

    Seo JH, Jun JS, Yeom JS, Park JS, Youn HS, Ko GH, et al. Changing pattern of antibiotic resistance of Helicobacter pylori in children during 20 years in Jinju, South Korea. Pediatr Int. 2013;55(3):332-6. [PubMed ID: 23279258]. https://doi.org/10.1111/ped.12048.

  • 4.

    Khademi F, Faghri J, Poursina F, Esfahani BN, Moghim S, Fazeli H, et al. Resistance pattern of Helicobacter pylori strains to clarithromycin, metronidazole, and amoxicillin in Isfahan, Iran. J Res Med Sci. 2013;18(12):1056-60. [PubMed ID: 24523796].

  • 5.

    Ogata SK, Godoy AP, da Silva Patricio FR, Kawakami E. High Helicobacter pylori resistance to metronidazole and clarithromycin in Brazilian children and adolescents. J Pediatr Gastroenterol Nutr. 2013;56(6):645-8. [PubMed ID: 23403439]. https://doi.org/10.1097/MPG.0b013e31828b3669.

  • 6.

    Malfertheiner P, Megraud F, O'Morain CA, Atherton J, Axon AT, Bazzoli F, et al. Management of Helicobacter pylori infection--the Maastricht IV/ Florence Consensus Report. Gut. 2012;61(5):646-64. [PubMed ID: 22491499]. https://doi.org/10.1136/gutjnl-2012-302084.

  • 7.

    Molina-Infante J, Romano M, Fernandez-Bermejo M, Federico A, Gravina AG, Pozzati L, et al. Optimized nonbismuth quadruple therapies cure most patients with Helicobacter pylori infection in populations with high rates of antibiotic resistance. Gastroenterology. 2013;145(1):121-128 e1. [PubMed ID: 23562754]. https://doi.org/10.1053/j.gastro.2013.03.050.

  • 8.

    Esmaeili-Dooki MR, Shirdel H, Hajiahmadi M. Eradication of Helicobacter pylori in Children by Triple Therapy Regimens of Amoxicillin, Omeprazole, and Clarithromycin or Azithromycin. Iran J Pediatr. 2015;25(6):2360. [PubMed ID: 26635936].

  • 9.

    Pacifico L, Osborn JF, Bonci E, Romaggioli S, Baldini R, Chiesa C. Probiotics for the treatment of Helicobacter pylori infection in children. World J Gastroenterol. 2014;20(3):673-83. [PubMed ID: 24574741]. https://doi.org/10.3748/wjg.v20.i3.673.

  • 10.

    Awaad AS, El-Meligy RM, Soliman GA. Natural products in treatment of ulcerative colitis and peptic ulcer. J Saudi Chem Soc. 2013;17(1):101-24.